ramucirumab,pembrolizumab
eli lilly,merck
['lung', 'friends']
exciting to see the results of a study for significant benefit for patients with #lungcancer #ascofriends #asco22 
Cancer Survivor and Cancer Advocate. Science Policy Analyst at @CancerResrch - tweets my own